Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W O Faustman

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Psychiatry Research|October 1, 1988
Luria-Nebraska performance and symptomatology in unmedicated schizophrenic patientsW O Faustman, J A Moses, J G Csernansky
The Journal of Nervous and Mental Disease|May 1, 1989
Independence of positive and negative symptoms in a population of schizophrenic patientsG P Guelfi, W O Faustman, J G Csernansky
Annals of Internal Medicine|October 24, 1998
Cholesterol and violence: is there a connection?W O Faustman, D L Ringo, S E Lindley
Biological Psychiatry|August 15, 1991
Limbic/mesolimbic connections and the pathogenesis of schizophreniaJ G Csernansky, G M Murphy, W O Faustman
Journal of Clinical Psychopharmacology|February 1, 1996
Validating the St. Hans rating scale with the abnormal involuntary movement scale (AIMS) in the assessment of tardive dyskinesiaD L Ringo, L M Half, W O Faustman
Proceedings. Symposium on Computer Applications in Medical Care|January 1, 1993
The side effects of antipsychotic drugs and patients' quality of life: patient education and preference assessment with computers and multimediaS E Morss, L A Lenert, W O Faustman
Psychiatry Research|March 1, 1990
Distinguishing depression and negative symptoms in unmedicated patients with schizophreniaJ W Newcomer, W O Faustman, W Yeh, et al.
Biological Psychiatry|June 15, 1994
Cholesterol and serotonin: seeking a possible link between blood cholesterol and CSF 5-HIAAD L Ringo, S E Lindley, K F Faull, et al.
Biological Psychiatry|January 1, 1993
CSF 5-HIAA and atmospheric pressure: failure to replicateW O Faustman, P J Elliott, D L Ringo, et al.
Archives of General Psychiatry|September 1, 1992
Zacopride in schizophrenia: a single-blind serotonin type 3 antagonist trialJ W Newcomer, W O Faustman, R B Zipursky, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Psychiatry Research|October 1, 1988
Luria-Nebraska performance and symptomatology in unmedicated schizophrenic patientsW O Faustman, J A Moses, J G Csernansky
The Journal of Nervous and Mental Disease|May 1, 1989
Independence of positive and negative symptoms in a population of schizophrenic patientsG P Guelfi, W O Faustman, J G Csernansky
Annals of Internal Medicine|October 24, 1998
Cholesterol and violence: is there a connection?W O Faustman, D L Ringo, S E Lindley
Biological Psychiatry|August 15, 1991
Limbic/mesolimbic connections and the pathogenesis of schizophreniaJ G Csernansky, G M Murphy, W O Faustman
Journal of Clinical Psychopharmacology|February 1, 1996
Validating the St. Hans rating scale with the abnormal involuntary movement scale (AIMS) in the assessment of tardive dyskinesiaD L Ringo, L M Half, W O Faustman
Proceedings. Symposium on Computer Applications in Medical Care|January 1, 1993
The side effects of antipsychotic drugs and patients' quality of life: patient education and preference assessment with computers and multimediaS E Morss, L A Lenert, W O Faustman
Psychiatry Research|March 1, 1990
Distinguishing depression and negative symptoms in unmedicated patients with schizophreniaJ W Newcomer, W O Faustman, W Yeh, et al.
Biological Psychiatry|June 15, 1994
Cholesterol and serotonin: seeking a possible link between blood cholesterol and CSF 5-HIAAD L Ringo, S E Lindley, K F Faull, et al.
Biological Psychiatry|January 1, 1993
CSF 5-HIAA and atmospheric pressure: failure to replicateW O Faustman, P J Elliott, D L Ringo, et al.
Archives of General Psychiatry|September 1, 1992
Zacopride in schizophrenia: a single-blind serotonin type 3 antagonist trialJ W Newcomer, W O Faustman, R B Zipursky, et al.
Pageof 6